Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Five Star Quality Care, Inc. (FVE) Stacks Up Against Its Peers

Page 1 of 2

The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge funds have been producing disappointing net returns in recent years, however that was partly due to the poor performance of small-cap stocks in general. Well, small-cap stocks finally turned the corner and have been beating the large-cap stocks by more than 10 percentage points over the last 5 months.This means the relevancy of hedge funds’ public filings became inarguable, as they may reveal numerous high-potential stocks. The following article will discuss the smart money sentiment towards Five Star Quality Care, Inc. (NASDAQ:FVE).

Five Star Quality Care, Inc. (NASDAQ:FVE) shareholders have witnessed a decrease in hedge fund interest lately. FVE was in 8 hedge funds’ portfolios at the end of the third quarter of 2016. There were 9 hedge funds in our database with FVE holdings at the end of the second quarter. At the end of this article we will also compare FVE to other stocks including Eiger Biopharmaceuticals Inc (NASDAQ:EIGR), Hugoton Royalty Trust (NYSE:HGT), and Catabasis Pharmaceuticals Inc (NASDAQ:CATB) to get a better sense of its popularity.

Follow Five Star Senior Living Inc.
Trade (NASDAQ:FVE) Now!

We follow over 700 hedge funds and other institutional investors and by analyzing their quarterly 13F filings, we identify stocks that they are collectively bullish on and develop investment strategies based on this data. One strategy that outperformed the market over the last year involves selecting the 100 best-performing funds and identifying the 30 mid-cap stocks that they are collectively most bullish on. Over the past year, this strategy generated returns of 18%, topping the 8% gain registered by S&P 500 ETFs. We launched this strategy 2.5 years ago and it returned more than 39% since then, vs. 22% gain registered by the S&P 500 ETFs.

care, senior, home, free, patient, medical, older, two, fun, horizontal, clinic, chill, therapist, male, disease, people, medicine, elderly, therapy, rest, time, retirement, woman,

Photographee.eu/Shutterstock.com

What have hedge funds been doing with Five Star Quality Care, Inc. (NASDAQ:FVE)?

At Q3’s end, a total of 8 of the hedge funds tracked by Insider Monkey were long this stock, an 11% drop from the second quarter of 2016, and the fourth straight quarter with a decline in hedge fund ownership of a single hedge fund in total. The graph below displays the number of hedge funds with bullish position in FVE over the last 5 quarters. So, let’s examine which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

HedgeFundSentimentChart

According to Insider Monkey’s hedge fund database, Renaissance Technologies, one of the largest hedge funds in the world, holds the number one position in Five Star Quality Care, Inc. (NASDAQ:FVE). Renaissance Technologies has a $4.9 million position in the stock. Sitting at the No. 2 spot is Axar Capital, led by Andrew Axelrod, holding a $4.6 million position. Remaining hedge funds and institutional investors that are bullish consist of George McCabe’s Portolan Capital Management, Vishal Saluja and Pham Quang’s Endurant Capital Management, and David E. Shaw’s D E Shaw. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds, which is based on the performance of their 13F long positions in non-micro-cap stocks.

Page 1 of 2